Literature DB >> 25157440

Bone tissue remodeling and development: focus on matrix metalloproteinase functions.

Katiucia Batista Silva Paiva1, José Mauro Granjeiro2.   

Abstract

Bone-forming cells originate from distinct embryological layers, mesoderm (axial and appendicular bones) and ectoderm (precursor of neural crest cells, which mainly form facial bones). These cells will develop bones by two principal mechanisms: intramembranous and endochondral ossification. In both cases, condensation of multipotent mesenchymal cells occurs, at the site of the future bone, which differentiate into bone and cartilage-forming cells. During long bone development, an initial cartilaginous template is formed and replaced by bone in a coordinated and refined program involving chondrocyte proliferation and maturation, vascular invasion, recruitment of adult stem cells and intense remodeling of cartilage and bone matrix. Matrix metalloproteinases (MMPs) are the most important enzymes for cleaving structural components of the extracellular matrix (ECM), as well as other non-ECM molecules in the ECM space, pericellular perimeter and intracellularly. Thus, the bioactive molecules generated act on several biological events, such as development, tissue remodeling and homeostasis. Since the discovery of collagenase in bone cells, more than half of the MMP members have been detected in bone tissues under both physiological and pathological conditions. Pivotal functions of MMPs during development and bone regeneration have been revealed by knockout mouse models, such as chondrocyte proliferation and differentiation, osteoclast recruitment and function, bone modeling, coupling of bone resorption and formation (bone remodeling), osteoblast recruitment and survival, angiogenesis, osteocyte viability and function (biomechanical properties); as such alterations in MMP function may alter bone quality. In this review, we look at the principal properties of MMPs and their inhibitors (TIMPs and RECK), provide an up-date on their known functions in bone development and remodeling and discuss their potential application to Bone Bioengineering.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone development; Bone remodeling; Extracellular Matrix; Matrix metalloproteinases; RECK, Bone Bioengineering; Tissue inhibitor of matrix metalloproteinases

Mesh:

Substances:

Year:  2014        PMID: 25157440     DOI: 10.1016/j.abb.2014.07.034

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  52 in total

1.  IDG-SW3 Osteocyte Differentiation and Bone Extracellular Matrix Deposition Are Enhanced in a 3D Matrix Metalloproteinase-Sensitive Hydrogel.

Authors:  Aaron H Aziz; Rachel L Wilmoth; Virginia L Ferguson; Stephanie J Bryant
Journal:  ACS Appl Bio Mater       Date:  2020-02-19

Review 2.  Defective skeletal mineralization in pediatric CKD.

Authors:  Katherine Wesseling-Perry
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

3.  A comparison of human mesenchymal stem cell osteogenesis in poly(ethylene glycol) hydrogels as a function of MMP-sensitive crosslinker and crosslink density in chemically defined medium.

Authors:  Aaron H Aziz; Stephanie J Bryant
Journal:  Biotechnol Bioeng       Date:  2019-03-05       Impact factor: 4.530

4.  Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

Authors:  Sun H Peck; John W Tobias; Eileen M Shore; Neil R Malhotra; Mark E Haskins; Margret L Casal; Lachlan J Smith
Journal:  Bone       Date:  2019-08-20       Impact factor: 4.398

Review 5.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 7.  Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials.

Authors:  Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

8.  Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients.

Authors:  K Thisiadou; V Liakopoulos; G Dimas; G Koliakos; M Karamouzis
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

9.  Hydroxamate-Based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging.

Authors:  Kiran Gona; Jakub Toczek; Yunpeng Ye; Nowshin Sanzida; Arvene Golbazi; Parnaz Boodagh; Mani Salarian; Jae-Joon Jung; Saranya Rajendran; Gunjan Kukreja; Terence L Wu; Laurent Devel; Mehran M Sadeghi
Journal:  J Med Chem       Date:  2020-11-18       Impact factor: 7.446

10.  Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications.

Authors:  Preety Panwar; Guillaume Lamour; Neil C W Mackenzie; Heejae Yang; Frank Ko; Hongbin Li; Dieter Brömme
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.